Standard Operating Procedure for Review and Approval of Registration Dossiers
| Department | Regulatory Affairs |
| SOP No. | RA/2026/658 |
| Supersedes | NA |
| Page No. | 1 of X |
| Issue Date | 10/04/2026 |
| Effective Date | 10/04/2026 |
| Review Date | 10/04/2028 |
Purpose
This Standard Operating Procedure (SOP) defines the systematic process for the comprehensive review and formal approval of registration dossiers intended for submission to regulatory authorities. It ensures that all dossiers meet applicable regulatory requirements, internal quality standards, and completeness criteria prior to submission, facilitating timely market authorization and compliance with global regulatory expectations.
Scope
This SOP applies to all registration dossiers prepared for any pharmaceutical dosage form, medical device, or related product within the organization intended for regulatory submission. It encompasses the review and approval activities carried out within the Regulatory Affairs department and interfaces with Quality Assurance, Clinical, Manufacturing, and other relevant departments. Activities excluded include post-approval regulatory maintenance and unrelated documentation processes.
Responsibilities
Functional roles involved include:
- Regulatory Affairs Reviewers – responsible for detailed dossier examination against regulatory and organizational criteria.
- Quality Assurance – responsible for verifying compliance with quality standards.
- Subject Matter Experts (e.g., Clinical, Manufacturing) – provide technical evaluations relevant to their domain.
- Regulatory Affairs Supervisors – oversee the review process, ensuring timelines and quality controls.
- Approving Authorities – grant final approval for dossier submission.
Accountability
The Head of Regulatory Affairs is accountable for the implementation, continual compliance, and periodic review of this SOP, ensuring its effectiveness through periodic audits and managing escalation processes when deviations or bottlenecks arise.
Procedure
The review and approval of registration dossiers shall be executed in a structured and controlled manner to guarantee regulatory compliance and dossier integrity as follows:
1. Preparation and Prerequisites: Prior to initiating review, confirm receipt of a complete dossier package as per the predefined dossier checklist. Verify that all supporting documents, templates, and annexures are current and authorized. Ensure availability of applicable regulatory guidelines and internal SOPs.
2. Initial Completeness Check: Conduct a preliminary assessment to confirm the dossier contains all mandatory sections, forms, and data sets. Identify any missing elements or discrepancies and communicate with dossier preparers for rectification.
3. Detailed Technical Review: Regulatory Affairs Reviewers shall examine all components for accuracy, consistency, and regulatory alignment. Cross-check clinical data, manufacturing information, labeling, and quality control documentation. Subject Matter Experts shall verify technical sections related to their expertise.
4. Compliance and GMP Verification: Quality Assurance shall assess adherence to Good Manufacturing Practices (GMP), Good Clinical Practices (GCP), and other applicable standards within the dossier’s content.
5. Deviation Identification and Resolution: Document any nonconformities or potential risks identified during review. Raise corrective actions or clarifications through established channels. Follow up to ensure satisfactory resolution before proceeding.
6. Approval Workflow: Upon satisfactory review and resolution of issues, compile reviewer comments and recommendations. Submit the dossier and associated findings to the designated Approving Authorities within Regulatory Affairs. Approval shall only be granted after thorough evaluation and endorsement of dossier integrity and compliance.
7. Documentation and Record Keeping: Retain all review records, checklists, approval forms, and correspondence in accordance with internal document control and record retention policies. Ensure traceability of all changes, sign-offs, and review dates for audit readiness.
8. Closure and Submission Preparation: Post-approval, inform relevant departments to proceed with dossier submission as per regulatory timelines and procedures. Archive approved dossiers securely to maintain confidentiality and data integrity.
Throughout all stages, maintain effective communication between involved departments and ensure adherence to timelines to support timely regulatory submissions. This procedure must be periodically reviewed and updated to incorporate evolving regulatory requirements and organizational changes.
Abbreviations
- GMP – Good Manufacturing Practices
- GCP – Good Clinical Practices
- QA – Quality Assurance
- RA – Regulatory Affairs
- SOP – Standard Operating Procedure
Documents
The following documents are essential for the review and approval process described in this SOP:
- Registration Dossier Checklist (Annexure-1)
- Dossier Review Comment Form (Annexure-2)
- Approval Form for Registration Dossier Submission (Annexure-3)
References
- ICH Q10 – Pharmaceutical Quality System
- FDA Guidance for Industry: Content and Format of Investigational New Drug Applications
- EU Directive 2001/83/EC on the Community Code Relating to Medicinal Products
- Internal Document Control SOP
- Good Manufacturing Practices (GMP) as applicable
Version
1.0
Approval
| Prepared By | |
| Checked By | |
| Approved By |
Annexures
Annexure-1: Registration Dossier Checklist
Purpose: To verify completeness and presence of all required components within the registration dossier prior to detailed review.
| Section | Status (Yes/No) | Comments |
|---|---|---|
| Cover Letter | Yes | Attached with correct date |
| Product Information | Yes | Includes dosage form and formulation |
| Clinical Data | Yes | All required study reports included |
| Manufacturing Process Description | Yes | Validated process details present |
| Quality Control Data | Yes | Analytical methods and results included |
| Labeling and Packaging | Yes | Approved artwork attached |
| Regulatory Forms and Declarations | Yes | Signed and dated as required |
| Other Supporting Documents | Yes | Environmental and safety data included |
Annexure-2: Dossier Review Comment Form
Purpose: To document detailed observations, comments, and action items identified during the dossier review process.
| Date | Reviewer Role | Section Reviewed | Comments | Action Required | Status |
|---|---|---|---|---|---|
| 05/04/2026 | Regulatory Affairs Reviewer | Clinical Data | Missing stability report for study XYZ. | Request stability report from Clinical Team. | Open |
| 06/04/2026 | Quality Assurance | Manufacturing Process | Validation batch records incomplete. | Follow-up with Manufacturing for completion. | Open |
| 08/04/2026 | Regulatory Affairs Supervisor | Overall Dossier | All comments addressed satisfactorily. | Proceed to Approval. | Closed |
Annexure-3: Approval Form for Registration Dossier Submission
Purpose: To document formal authorization for the submission of the registration dossier to the relevant regulatory authority.
| Document Title | Registration Dossier for Product ABC |
| Date of Approval | 09/04/2026 |
| Approving Authority | Head of Regulatory Affairs |
| Comments | All reviews completed. Dossier approved for submission. |
| Signature | _________________________ |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
| 10/04/2026 | 1.0 | Initial issue | New SOP creation |